formaldehyde has been researched along with sr 144528 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosino, G; Beaulieu1, P; Bisogno1, T; Di Marzo, V; Farquhar-Smith, WP; Punwar, S; Rice, AS | 1 |
| Calignano, A; La Rana, G; Piomelli, D | 1 |
| Burgos, E; Goicoechea, C; MartÃn, MI; Pascual, D | 1 |
3 other study(ies) available for formaldehyde and sr 144528
| Article | Year |
|---|---|
Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat.
Topics: Animals; Camphanes; Cannabinoid Receptor Modulators; Formaldehyde; Hyperalgesia; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2000 |
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.
Topics: Amides; Analgesics; Analysis of Variance; Animals; Arachidonic Acids; Calcium Channel Blockers; Camphanes; Dose-Response Relationship, Drug; Drug Synergism; Endocannabinoids; Ethanolamines; Formaldehyde; Male; Mice; Pain; Palmitic Acids; Polyunsaturated Alkamides; Pyrazoles | 2001 |
Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
Topics: Analgesics; Analgesics, Opioid; Anesthetics, Dissociative; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Benzoxazines; Camphanes; Facial Pain; Formaldehyde; Indomethacin; Inflammation; Ketamine; Male; Morphine; Morpholines; Motor Activity; Naphthalenes; Pain; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Temporomandibular Joint Disorders | 2010 |